Chemical and Biological Defense Program

JTIWG, through the Chemical, Biological, Radiological and Nuclear Defense (CBRND) Test and Evaluation (T&E) Executive, is responsible for overseeing Enterprise-wide processes to develop and sustain standardized T&E methodologies and validated instrumentation and infrastructure to ensure the adequacy of test for CBRND systems in alignment with acquisition milestones and associated decision points.

OSD MGT performs program reviews/assessments, provides programmatic planning, programming, budgeting, and execution (PPBE) oversight/analysis, provides Congressional issue analysis and support, and financial management. OSD MGT also provides the CBDP Enterprise all aspects of accounting, to include financial statements, reconciliation of budgetary and proprietary accounts, and compliance.

Conduct independent analysis and provide objective advice to the CBDP and its stakeholders. Ensure CB defense programs mission areas, policies, and processes support operational requirements, promote efficiency and readiness, and enhance data management and advanced analytics capabilities to streamline administration of program life-cycle activities.

Provides centralized DoD expertise, implements biosafety improvements, and adds protections for CBDP defense industrial supply chain, tools and intellectual property.

JCSA supports foundational Joint Concepts development, studies/assessments and analyses to enable requirements and capabilities development of both medical and physical chemical and biological (CB) defense systems; coordinates weapons of mass destruction (WMD)/CB threat information requirements; and conducts integrated CB risk assessments.

Facilitates Chairman of the Joint Chiefs of Staff (CJCS) development of military advice through the assessment of capability needs, identification of capability gaps, and development of Joint chemical and biological (CB) operational capability requirements. Represents the Services and Combatant Commands (CCMD) in the development of materiel and non-materiel solutions.

The JACKS DBS provides a centralized repository of chemical and biological systems acquisition information and analytic tools.

The CBDP Executive Agent Management coordinates and integrates research, development, test and evaluation, and acquisition requirements of the Military Departments and National Guard Bureau for chemical and biological warfare defense.

The BDMR COP will increase situational awareness of biodefense readiness through a biodefense logistics common operating picture (COP) to ensure preparedness and enable a more rapid response to biological threats. The platform will enable the biodefense enterprise to monitor assets and acquisition programs to consolidate data streams into executive dashboards, working level planning tools to provide material readiness status, and provide supply chain visibility and illuminations. This situational awareness of required biodefense materiel capabilities, including medical and non-medical personal protective equipment, will also enable leaders to track and manage the necessary capabilities to protect the Total Force and mitigate the effects of biological incidents. This effort will enable a holistic approach to addressing supply chain risk management, resiliency and security to across the entire biological defense aperture.

BSAT BBPO supports the DoD EA and EA Responsible Official (EARO) for BSAT Biosafety and Biosecurity Programs in their responsibilities for mission oversight, technical review, inspection, harmonization of biosafety and biosecurity protocols and procedures across DoD laboratories handling BSAT. This effort supports the Scientific Gaps in Biorisk Research Program (SGBRP) to address gaps in scientific knowledge to facilitate validation of BSAT protocols and procedures, ensuring compliance with Title 50 USC § 1527, "Improved biosafety for handling of select agents and toxins." Closing these gaps will reduce the inherent risks associated with BSAT research in DoD laboratories, support research and development work on priority agents, and complies with Federal BSAT regulations (42 CFR 73, 9 CFR 121, and 7 CFR 331). Research projects, selected from an order of merit list, are funded for one year.

The Biological Safety (BSAT) Biorisk Program Office (BBPO) supports the DoD Executive Agent (EA) and EA Responsible Official (EARO) for BSAT Biosafety and Biosecurity Programs in their responsibilities for mission oversight, technical review, inspection, harmonization of biosafety and biosecurity protocols and procedures across DoD laboratories handling BSAT. This effort supports the Scientific Gaps in Biorisk Research Program (SGBRP) to address gaps in scientific knowledge to facilitate validation of BSAT protocols and procedures, ensuring compliance with Title 50 USC § 1527, "Improved biosafety for handling of select agents and toxins." Closing these gaps will reduce the inherent risks associated with BSAT research in DoD laboratories, support research and development work on priority agents, and complies with Federal BSAT regulations (42 CFR 73, 9 CFR 121, and 7 CFR 331). Research projects, selected from an order of merit list, are funded for one year.

AMIEE will develop a U.S. based full ensemble mannikin test capability. AMIEE is a modernized, humanoid robot that allows for full individual ensemble permeation testing.

MRDC laboratory infrastructure provides for laboratory operations, facilities sustainment, and regulatory compliance for critical CB defense activities at the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID) and the U.S. Army Medical Research Institute for Chemical Defense (USAMRICD) to counter an expanding threat space, exploit advances in technology, and develop and transition CB defense equipment and countermeasures to the warfighter.

The U.S. Army Combat Capabilities Development Command (DEVCOM) Chemical Biological Center (CBC) laboratory infrastructure funding is dedicated to sustaining and modernizing research, development, testing, and support for Chemical and Biological Defense (CBD) capabilities, empowering the Joint Force to succeed in challenging environments. DEVCOM CBC focuses on exploring, evaluating, demonstrating, and testing the operational effectiveness of Integrated Early Warning and Integrated Layered Defense strategies, which are crucial for enhancing the warfighter's decision-making abilities. DEVCOM CBC is instrumental in updating the Army and Department of Defense's biodefense capabilities. Additionally, it assesses and characterizes emerging threats to prevent their use and avoid surprises, while also exploring, prototyping, and integrating CBD technology into combat platforms.